BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 34347247)

  • 1. State-of-the-art Hepatocellular Carcinoma Biomarker Detection by Biosensor Technology-a Review.
    Uygun ZO
    J Gastrointest Cancer; 2021 Sep; 52(3):1081-1085. PubMed ID: 34347247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamers and New Bioreceptors for the Electrochemical Detection of Biomarkers Expressed in Hepatocellular Carcinoma.
    Pusta A; Tertis M; Graur F; Cristea C; Al Hajjar N
    Curr Med Chem; 2022; 29(25):4363-4390. PubMed ID: 35196969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-step detection for two serological biomarker species to improve the diagnostic accuracy of hepatocellular carcinoma.
    Gao T; Zhi J; Mu C; Gu S; Xiao J; Yang J; Wang Z; Xiang Y
    Talanta; 2018 Feb; 178():89-93. PubMed ID: 29136911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optical and Electrochemical Aptasensors Developed for the Detection of Alpha-Fetoprotein.
    Tran Ngoc Huy D; Iswanto AH; Catalan Opulencia MJ; Al-Saikhan F; Timoshin A; Abed AM; Ahmad I; Blinova SA; Hammid AT; Mustafa YF; Van Tuan P
    Crit Rev Anal Chem; 2024; 54(4):857-871. PubMed ID: 35969067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An automated and mobile magnetoresistive biosensor system for early hepatocellular carcinoma diagnosis.
    Yao C; Ng E; Wang SX
    Biosens Bioelectron; 2022 Apr; 202():113982. PubMed ID: 35033828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
    Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
    Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovering the digital biomarker of hepatocellular carcinoma in serum with SERS-based biosensors and intelligence vision.
    Cheng N; Lou B; Wang H
    Colloids Surf B Biointerfaces; 2023 Jun; 226():113315. PubMed ID: 37086688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological Features of Two Extremely Rare Hepatocellular Carcinoma Variants: a Brief Review of Fibrolamellar and Scirrhous Hepatocellular Carcinoma.
    Samdanci ET; Akatli AN; Soylu NK
    J Gastrointest Cancer; 2020 Dec; 51(4):1187-1192. PubMed ID: 32860202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma-Literature Review.
    Kopystecka A; Patryn R; Leśniewska M; Budzyńska J; Kozioł I
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peptide network for detection of tissue-remodeling enzyme in the prognosis of hepatocellular carcinoma.
    Yu Y; Li H; Zhang B; Pan X; Zhu X; Ding Y; Li G
    ACS Appl Mater Interfaces; 2015 Feb; 7(7):4401-5. PubMed ID: 25629926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
    Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
    Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells in Hepatocellular Carcinoma: A Comprehensive Review and Critical Appraisal.
    Espejo-Cruz ML; González-Rubio S; Zamora-Olaya J; Amado-Torres V; Alejandre R; Sánchez-Frías M; Ciria R; De la Mata M; Rodríguez-Perálvarez M; Ferrín G
    Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circular RNA 0068669 as a new biomarker for hepatocellular carcinoma metastasis.
    Yao T; Chen Q; Shao Z; Song Z; Fu L; Xiao B
    J Clin Lab Anal; 2018 Oct; 32(8):e22572. PubMed ID: 29785842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics for hepatocellular carcinoma marker discovery.
    Chignard N; Beretta L
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S120-5. PubMed ID: 15508075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets' RNA as biomarker trove for differentiation of early-stage hepatocellular carcinoma from underlying cirrhotic nodules.
    Waqar W; Asghar S; Manzoor S
    PLoS One; 2021; 16(9):e0256739. PubMed ID: 34469466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
    Gottschalk-Sabag S; Ron N; Glick T
    Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to improve the histopathological diagnosis of hepatocellular carcinoma in daily practice?].
    Honsová E; Lodererová A
    Cesk Patol; 2011 Apr; 47(2):40-3. PubMed ID: 21604432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of phenol 2,2-methylene bis, 6 [1,1-D] as breath biomarker of hepatocellular carcinoma (HCC) patients and its electrochemical sensing: E-nose biosensor for HCC.
    Nazir NU; Abbas SR
    Anal Chim Acta; 2023 Feb; 1242():340752. PubMed ID: 36657885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Alpha-Fetoprotein in Hepatocellular Carcinoma Patient Plasma with Graphene Field-Effect Transistor.
    Kim DH; Oh HG; Park WH; Jeon DC; Lim KM; Kim HJ; Jang BK; Song KS
    Sensors (Basel); 2018 Nov; 18(11):. PubMed ID: 30463232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.